Ezetimibe and Lenalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ezetimibe (ezetimibe) and Lenalidomide (lenalidomide). Common drug interactions include abdominal pain upper among females and lymphopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Ezetimibe and Lenalidomide. It is created by eHealthMe based on reports of 94 people who take the same drugs from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

94 people who take Ezetimibe and Lenalidomide together, and have interactions are studied.

Ezetimibe and Lenalidomide drug interactions.

What are the common drug interactions of Ezetimibe and Lenalidomide, by gender? *:

female:

Abdominal pain upper
Alopecia (absence of hair from areas of the body)
Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Arthralgia (joint pain)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Cardiac failure congestive
Catheter site inflammation (infection at catheter site)
Cystitis (inflammation of the wall of the bladder)
Cytomegalovirus infection

male:

Lymphopenia (an abnormally low level of lymphocytes in the blood)
Anaemia (lack of blood)
Thrombocytopenia (decrease of platelets in blood)
Purpura (purplish discoloration of the skin)
Hospitalisation
Pneumonia
Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
Rectal polyp (fleshy growth occurring on the lining of the colon)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Confusional state

What are the common drug interactions of Ezetimibe and Lenalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot)
Anaemia (lack of blood)

50-59:

Anaemia (lack of blood)
General physical health deterioration (weak health status)
Nausea (feeling of having an urge to vomit)
Abscess (pus)
Arthralgia (joint pain)
Epistaxis (bleed from the nose)
Hepatic failure (liver failure)
Melaena (the passage of black, tarry stools)
Petechiae (a small red or purple spot caused by bleeding into the skin)
Pyrexia (fever)

60+:

Lymphopenia (an abnormally low level of lymphocytes in the blood)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Pruritus (severe itching of the skin)
Septic shock (shock due to blood infection)
Thrombocytopenia (decrease of platelets in blood)
Diarrhoea
Purpura (purplish discoloration of the skin)
Dyspnoea (difficult or laboured respiration)
Thrombosis (formation of a blood clot inside a blood vessel)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 58 people, 61.70%
High Blood Pressure: 9 people, 9.57%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 7 people, 7.45%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 7 people, 7.45%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and Lenalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously